TARS – tarsus pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) had its price target raised by analysts at HC Wainwright from $57.00 to $61.00. They now have a "buy" rating on the stock.
Earnings Update: Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Just Reported And Analysts Are Boosting Their Estimates [Yahoo! Finance]
Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) had its price target raised by analysts at Barclays PLC from $50.00 to $60.00. They now have an "overweight" rating on the stock.
Tarsus Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
Tarsus to Participate in Fireside Chat at the 2024 Bank of America Healthcare Conference
Form 10-Q Tarsus Pharmaceuticals, For: Mar 31
Form 8-K Tarsus Pharmaceuticals, For: May 08
Form ARS Tarsus Pharmaceuticals, For: Dec 31
Form DEFA14A Tarsus Pharmaceuticals,
Form DEF 14A Tarsus Pharmaceuticals, For: Jun 13
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.